Lysosome-Targeting Nanochimeras Attenuating Liver Fibrosis by Interconnected Transforming Growth Factor-β Reduction and Activin Receptor-Like Kinase 5 DegradationHanshu Liu, Hongxia Liang, Yingqiu Qi et al.|ACS Nano|2025Cited by 18
LRG1-Targeted Nintedanib Delivery for Enhanced Renal Fibrosis MitigationYana Zhang, Yingqiu Qi, Furong Zhu et al.|Nano Letters|2024Cited by 14
LRG1-Targeted Camptothecin Nanomicelles with Simultaneous Delivery of Olaparib for Enhanced Colorectal Cancer ChemotherapyLin Du, Gang Wu, Huan Min et al.|Nano Letters|2025Cited by 12
Targeted degradation of LRG1 to attenuate renal fibrosisLinyao Fan, Huan Min, Yingqiu Qi et al.|Asian Journal of Pharmaceutical Sciences|2024Cited by 9
Ionizable Nano‐PROTAC Overcomes Endosomal Entrapment for Enhanced LRG1 Degradation and Tumor SuppressionHuan Min, Yingqiu Qi, Meng Sun et al.|Angewandte Chemie International Edition|2025Cited by 4